Market Tracker

10/24 2:50pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.01
Data as of 2:21pm ET
 -0.01 / -0.98%
Today’s Change
0.78
Today|||52-Week Range
1.83
-12.93%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.02
Today’s open1.06
Day’s range1.00 - 1.08
Volume159,207
Average volume (3 months)538,674
Market cap$45.0M
Dividend yield--
Data as of 2:21pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio1.7
Price/Sales1.47
Price/Book8.56

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...-0.03-1.36%
BLRXBioLine RX Ltd+0.01+0.74%
SPHSSophiris Bio Inc-0.04-1.44%
ANTHAnthera Pharmaceutic...+0.06+3.06%
Data as of 2:35pm ET, 10/24/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts